Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EIG | -23.56% | $1.13B | +10.51% | 2.59% |
UFCS | -22.23% | $725.35M | +32.62% | 2.28% |
QLYS | -19.84% | $5.12B | -1.10% | 0.00% |
GEO | -19.75% | $3.36B | +65.60% | 0.00% |
CXW | -18.66% | $2.27B | +60.02% | 0.00% |
MRCY | -18.39% | $3.19B | +97.89% | 0.00% |
SAFT | -17.61% | $1.17B | +5.08% | 4.56% |
SXC | -15.90% | $692.45M | -16.53% | 5.56% |
PRA | -13.13% | $1.17B | +86.82% | 0.00% |
MCFT | -12.74% | $313.17M | -0.11% | 0.00% |
STRA | -12.24% | $2.08B | -22.38% | 2.81% |
CHCO | -12.22% | $1.78B | +16.00% | 2.49% |
CWCO | -12.22% | $474.80M | +12.40% | 1.42% |
SCI | -11.82% | $11.62B | +14.79% | 1.52% |
FYBR | -11.81% | $9.08B | +38.66% | 0.00% |
NWBI | -11.47% | $1.64B | +11.08% | 6.23% |
KLTR | -11.47% | $305.70M | +65.83% | 0.00% |
CVS | -11.44% | $86.64B | +15.97% | 3.87% |
RYI | -11.25% | $711.53M | +13.33% | 3.38% |
YORW | -11.16% | $458.51M | -14.15% | 2.70% |
Double maintains 4 strategies that include EXAS - EXACT Sciences Corp.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FBT | 37.66% | $1.01B | 0.54% |
FXH | 36.06% | $898.02M | 0.62% |
FBY | 34.82% | $175.97M | 1.06% |
IHI | 34.81% | $4.54B | 0.4% |
BBH | 34.77% | $329.40M | 0.35% |
QDVO | 33.56% | $80.30M | 0.55% |
GNOM | 33.43% | $44.21M | 0.5% |
SRVR | 33.38% | $438.81M | 0.55% |
ICF | 33.36% | $1.91B | 0.33% |
XLRE | 33.22% | $7.34B | 0.09% |
PBD | 32.86% | $71.19M | 0.75% |
DFGR | 32.57% | $2.50B | 0.22% |
DFAR | 32.36% | $1.33B | 0.19% |
BBRE | 32.30% | $885.71M | 0.11% |
FREL | 32.26% | $1.04B | 0.084% |
IYR | 32.22% | $3.77B | 0.39% |
PAWZ | 32.17% | $61.97M | 0.5% |
VNQ | 31.89% | $33.21B | 0.13% |
USRT | 31.83% | $2.91B | 0.08% |
REET | 31.72% | $4.04B | 0.14% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IRM | 43.19% | $30.18B | +14.15% | 2.93% |
AMWL | 41.74% | $125.53M | +22.23% | 0.00% |
SHAK | 39.98% | $5.57B | +53.87% | 0.00% |
ALNY | 39.58% | $42.09B | +32.85% | 0.00% |
IFF | 39.22% | $19.02B | -21.91% | 2.16% |
CDNA | 38.92% | $1.07B | +23.82% | 0.00% |
MX | 38.12% | $146.06M | -16.84% | 0.00% |
ILMN | 35.78% | $15.01B | -9.19% | 0.00% |
CLVT | 35.48% | $2.94B | -24.25% | 0.00% |
META | 35.33% | $1.84T | +45.50% | 0.28% |
LH | 34.69% | $21.80B | +28.05% | 1.10% |
PACS | 34.57% | $2.02B | -55.97% | 0.00% |
APD | 34.45% | $62.84B | +9.42% | 2.53% |
CHRW | 33.66% | $11.48B | +9.69% | 2.57% |
JAKK | 33.39% | $228.61M | +14.52% | 2.41% |
TTEK | 33.20% | $9.39B | -12.85% | 1.32% |
QGEN | 33.18% | $10.34B | +13.03% | 0.00% |
SNN | 33.18% | $13.22B | +21.95% | 2.46% |
A | 33.11% | $33.85B | -8.07% | 0.81% |
TECH | 32.99% | $8.13B | -27.65% | 0.62% |
Current Value
$53.571 Year Return
Current Value
$53.571 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IVOL | -21.87% | $351.30M | 1.02% |
TAIL | -18.93% | $99.76M | 0.59% |
BTAL | -18.61% | $296.79M | 1.43% |
VIXY | -18.33% | $165.69M | 0.85% |
STPZ | -14.98% | $450.22M | 0.2% |
VTIP | -12.07% | $15.34B | 0.03% |
SHYM | -11.47% | $349.95M | 0.35% |
USDU | -11.16% | $162.92M | 0.5% |
TDTT | -10.84% | $2.63B | 0.18% |
ULST | -10.76% | $662.59M | 0.2% |
SPTS | -10.65% | $5.78B | 0.03% |
TPMN | -10.30% | $30.77M | 0.65% |
FTSD | -10.17% | $231.79M | 0.25% |
XONE | -10.13% | $585.86M | 0.03% |
UUP | -9.26% | $237.02M | 0.77% |
TBLL | -8.44% | $2.14B | 0.08% |
STIP | -8.18% | $12.71B | 0.03% |
VGSH | -7.92% | $22.80B | 0.03% |
UTWO | -7.33% | $379.36M | 0.15% |
BIL | -7.07% | $42.87B | 0.1356% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
EZBC | -0.01% | $551.19M | 0.29% |
GBTC | -0.01% | $19.96B | 1.5% |
BTCO | -0.02% | $555.61M | 0.39% |
BTCW | 0.05% | $166.40M | 0.3% |
IBIT | -0.08% | $74.65B | 0.25% |
BSCP | 0.10% | $3.28B | 0.1% |
AGGH | 0.10% | $323.99M | 0.29% |
ARKB | -0.10% | $4.88B | 0.21% |
FBTC | -0.12% | $21.49B | 0.25% |
BITB | -0.13% | $4.24B | 0.2% |
BRRR | -0.15% | $629.51M | 0.25% |
YBTC | -0.19% | $226.96M | 0.96% |
HODL | -0.23% | $1.68B | 0.25% |
BITO | 0.23% | $2.55B | 0.95% |
DEFI | 0.26% | $14.62M | 0.94% |
SCHP | 0.27% | $13.50B | 0.03% |
SPTI | -0.37% | $8.78B | 0.03% |
SHV | -0.38% | $20.67B | 0.15% |
KBE | -0.42% | $1.48B | 0.35% |
TDTF | -0.47% | $839.47M | 0.18% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RDFN | 0.01% | $1.44B | +86.86% | 0.00% |
NOC | 0.02% | $71.10B | +13.32% | 1.72% |
HII | 0.02% | $9.36B | -3.12% | 2.24% |
CNOB | 0.03% | $1.17B | +23.88% | 3.06% |
LOB | 0.04% | $1.37B | -14.32% | 0.40% |
PRPO | -0.04% | $16.43M | +109.40% | 0.00% |
KAI | -0.04% | $3.69B | +6.72% | 0.41% |
MSM | 0.04% | $4.76B | +7.78% | 3.95% |
LANC | 0.05% | $4.74B | -9.09% | 2.18% |
VTOL | 0.05% | $959.66M | -0.54% | 0.00% |
VVX | 0.06% | $1.53B | +0.71% | 0.00% |
TNET | 0.06% | $3.52B | -27.33% | 1.40% |
RTO | -0.08% | $12.28B | -17.64% | 2.48% |
CFR | -0.08% | $8.29B | +26.86% | 2.98% |
TLPH | 0.09% | $9.60M | -47.42% | 0.00% |
CNK | 0.11% | $3.46B | +39.22% | 0.53% |
EXC | -0.11% | $43.32B | +23.98% | 3.65% |
NHC | -0.12% | $1.67B | -0.24% | 2.26% |
ONB | 0.13% | $7.91B | +24.32% | 2.61% |
KNOP | 0.13% | $219.16M | -27.14% | 1.64% |
Yahoo
Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter, the Fund (Investor Shares) returned -8.59% (net of fees), outperforming the Russell 1000 Growth Index’s -9.97% decline. In the first quarter, post-election optimism, driven by […]
Yahoo
Gilead Sciences shares rose Friday after the Supreme Court tossed out a challenge that would have impacted HIV PrEP drugs.
Yahoo
Exact Sciences’ first quarter results were met with a positive market response, reflecting notable improvements in commercial execution and the successful launch of new products. Management credited the double-digit revenue growth to expanded provider engagement, increased adoption of Cologuard and care gap programs, and early traction from Cologuard Plus. CEO Kevin Conroy emphasized that the commercial organization’s focus on targeting high-potential providers led to a 30% increase in customer
Yahoo
QGEN vs. EXAS: Which Stock Is the Better Value Option?
Yahoo
Exact Sciences Corporation (NASDAQ:EXAS) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. It has released fresh data from the Beta-CORRECT study that validates the clinical efficacy of its tumor-informed Oncodetect™ test for recurrence monitoring in stage II-IV colorectal cancer. The findings, presented at ASCO 2025, revealed that patients with ctDNA-positive […]
Yahoo
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Regeneron (NASDAQ:REGN) and its peers.